Previous close | 95.73 |
Open | 95.08 |
Bid | 92.31 x 900 |
Ask | 95.51 x 2900 |
Day's range | 93.37 - 95.53 |
52-week range | 70.74 - 97.97 |
Volume | |
Avg. volume | 448,891 |
Market cap | 4.838B |
Beta (5Y monthly) | 0.33 |
PE ratio (TTM) | 41.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.